StockData
MannKind Corp logo

MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30109% above fair value
$3.85−0.10 (-2.53%)

Close on Nov 20, 2026Market cap $1.24BP/E –Yield –

MannKind gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

MannKind's gross profit for the twelve months ending Jun 30, 2026 was $353.29M, up 23.8% year over year. For fiscal 2025 it was $322.17M, up 20.2% from the year before. The highest annual figure on record is $322.17M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$322.17M+20.2%
FY2024Dec 31, 2024$268.08M+50.5%
FY2023Dec 31, 2023$178.10M+112.6%
FY2022Dec 31, 2022$83.77M+42.9%
FY2021Dec 31, 2021$58.61M+17.1%
FY2020Dec 31, 2020$50.06M+16.5%
FY2019Dec 31, 2019$42.96M+407.4%
FY2018Dec 31, 2018$8.47M–
FY2017Dec 31, 2017-$5.48M-103.5%
FY2016Dec 31, 2016$157.64M–
FY2015Dec 31, 2015-$64.75M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$94.97M+32.0%
Q1 FY2026Mar 31, 2026$82.66M+10.8%
Q4 FY2025Dec 31, 2025$98.03M+36.2%
Q3 FY2025Sep 30, 2025$77.63M+16.1%
Q2 FY2025Jun 30, 2025$71.92M+7.7%
Q1 FY2025Mar 31, 2025$74.59M+19.4%
Q4 FY2024Dec 31, 2024$71.97M+37.5%
Q3 FY2024Sep 30, 2024$66.88M+41.5%
Q2 FY2024Jun 30, 2024$66.78M+53.9%
Q1 FY2024Mar 31, 2024$62.44M+77.9%
Q4 FY2023Dec 31, 2023$52.36M+63.7%
Q3 FY2023Sep 30, 2023$47.26M+70.0%
Q2 FY2023Jun 30, 2023$43.39M+203.9%
Q1 FY2023Mar 31, 2023$35.10M+261.5%
Q4 FY2022Dec 31, 2022$31.98M+289.0%
Q3 FY2022Sep 30, 2022$27.80M+51.1%
Q2 FY2022Jun 30, 2022$14.28M-24.3%
Q1 FY2022Mar 31, 2022$9.71M-26.0%
Q4 FY2021Dec 31, 2021$8.22M-44.4%
Q3 FY2021Sep 30, 2021$18.40M+56.4%
Q2 FY2021Jun 30, 2021$18.87M+65.0%
Q1 FY2021Mar 31, 2021$13.12M+8.7%
Q4 FY2020Dec 31, 2020$14.79M+30.2%
Q3 FY2020Sep 30, 2020$11.76M+56.9%
Q2 FY2020Jun 30, 2020$11.44M+7.1%
Q1 FY2020Mar 31, 2020$12.07M-10.1%
Q4 FY2019Dec 31, 2019$11.36M+2.9%
Q3 FY2019Sep 30, 2019$7.50M–
Q2 FY2019Jun 30, 2019$10.68M–
Q1 FY2019Mar 31, 2019$13.43M–
Q4 FY2018Dec 31, 2018$11.05M–
Q3 FY2018Sep 30, 2018-$834.00K–
Q2 FY2018Jun 30, 2018-$1.20M–
Q1 FY2018Mar 31, 2018-$543.00K-217.8%
Q4 FY2017Dec 31, 2017-$488.00K-106.0%
Q3 FY2017Sep 30, 2017-$2.53M-101.6%
Q2 FY2017Jun 30, 2017-$2.92M–
Q1 FY2017Mar 31, 2017$461.00K–
Q4 FY2016Dec 31, 2016$8.20M–
Q3 FY2016Sep 30, 2016$157.96M–

More MannKind figures

See a number that looks wrong?